Geranylgeranylacetone promotes induction and secretion of thioredoxin in gastric mucosal cells and peripheral blood lymphocytes

Thioredoxin (TRX) is a redox-active protein which is induced by oxidative stresses and shows a variety of biological activities including cytoprotection against oxidative stress. We recently reported that geranylgeranylacetone (GGA), an anti-ulcer drug, induces TRX in rat hepatocytes. In this study, we demonstrate that GGA promotes induction and secretion of TRX in rat gastric mucosal cells and human peripheral blood lymphocytes (PBLs). Western blotting and a sensitive sandwich ELISA showed that TRX was induced by GGA in the cell lysates and culture supernatants of rat gastric mucosal RGM-1 cells and human PBLs. LDH releasing assay showed that GGA protected rat gastric mucosal RGM-1 cells from ethanol-induced cytotoxicity. Moreover, exogenous recombinant wild type TRX decreased 51Cr release from primary cultured rat gastric mucosal cells incubated with ethanol or hydrogen peroxide in a dose-dependent manner, whereas recombinant mutant TRX (C32S/C35S), in which the two cysteines were replaced with serines in its active site, did not. These results indicate that GGA promotes the induction and secretion of TRX in a variety of types of cells and suggest that induced or secreted TRX may play an important role in the cytoprotective action of GGA on gastric mucosal cells.

[1]  H. Nakamura,et al.  Geranylgeranylacetone enhances expression of thioredoxin and suppresses ethanol-induced cytotoxicity in cultured hepatocytes. , 2000, Biochemical and biophysical research communications.

[2]  K. Dohi,et al.  Oral administration of geranylgeranylacetone protects rat livers from warm ischemic injury. , 1999, Transplantation proceedings.

[3]  T. Horie,et al.  Thioredoxin negatively regulates p38 MAP kinase activation and IL-6 production by tumor necrosis factor-alpha. , 1999, Biochemical and biophysical research communications.

[4]  K. Nozaki,et al.  Overexpression of thioredoxin in transgenic mice attenuates focal ischemic brain damage. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[5]  T. Ogihara,et al.  Pancreatic β Cell–specific Expression of  Thioredoxin, an Antioxidative and Antiapoptotic Protein, Prevents Autoimmune and Streptozotocin-induced Diabetes , 1998, The Journal of experimental medicine.

[6]  M. Besnard,et al.  Release of Thioredoxin via the Mechanosensitive Channel MscL during Osmotic Downshock of Escherichia coli Cells* , 1998, The Journal of Biological Chemistry.

[7]  Kohei Miyazono,et al.  Mammalian thioredoxin is a direct inhibitor of apoptosis signal‐regulating kinase (ASK) 1 , 1998, The EMBO journal.

[8]  K. Nozaki,et al.  Redox Control of Neuronal Damage during Brain Ischemia after Middle Cerebral Artery Occlusion in the Rat: Immunohistochemical and Hybridization Studies of Thioredoxin , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[9]  J. Yodoi,et al.  Induction of human thioredoxin in cultured human retinal pigment epithelial cells through cyclic AMP-dependent pathway; involvement in the cytoprotective activity of prostaglandin E1. , 1997, Experimental eye research.

[10]  K. Mori,et al.  AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[11]  H. Nakamura,et al.  Redox regulation of cellular activation. , 1997, Annual review of immunology.

[12]  K. Rokutan,et al.  Geranylgeranylacetone induces heat shock proteins in cultured guinea pig gastric mucosal cells and rat gastric mucosa. , 1996, Gastroenterology.

[13]  T. Takemoto,et al.  Clinical evaluation of teprenone, a mucosal protective agent, in the treatment of patients with gastric ulcers: a nationwide, multicenter clinical study. , 1995, Clinical therapeutics.

[14]  Y. Yamaoka,et al.  Adult T cell leukemia-derived factor/human thioredoxin protects endothelial F-2 cell injury caused by activated neutrophils or hydrogen peroxide. , 1994, Immunology letters.

[15]  K. Inui,et al.  Effect of recombinant human adult T cell leukemia-derived factor on rat lung reperfusion injury. , 1994, Respiration; international review of thoracic diseases.

[16]  R. Sitia,et al.  Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway. , 1992, The Journal of biological chemistry.

[17]  J. Yodoi,et al.  Reactive oxygen-reducing and protein-refolding activities of adult T cell leukemia-derived factor/human thioredoxin. , 1992, Biochemical and biophysical research communications.

[18]  H. Nakamura,et al.  Protective activity of adult T cell leukemia-derived factor (ADF) against tumor necrosis factor-dependent cytotoxicity on U937 cells. , 1991, Journal of immunology.

[19]  K. Sagara,et al.  Gastric mucosal hexosamine content in various liver diseases. , 1991, Hepato-Gastroenterology.

[20]  K. Arai,et al.  ATL‐derived factor (ADF), an IL‐2 receptor/Tac inducer homologous to thioredoxin; possible involvement of dithiol‐reduction in the IL‐2 receptor induction. , 1989, The EMBO journal.

[21]  A. Slomiany,et al.  Protection against alcohol-induced gastric mucosal injury by geranylgeranylacetone: effect of indomethacin. , 1988, Digestion.

[22]  H. Hansson,et al.  Thioredoxin and thioredoxin reductase show function-related changes in the gastric mucosa: immunohistochemical evidence. , 1988, Acta physiologica Scandinavica.

[23]  A. Terano,et al.  Protective action of tetraprenylacetone against ethanol-induced damage in rat gastric mucosa. , 1986, Digestion.

[24]  M. Itô,et al.  Healing-promoting action of teprenone, a new antiulcer agent on acetic acid ulcer in rats. , 1985, Japanese Journal of Pharmacology.

[25]  T. Yamanaka,et al.  Effects of geranylgeranylacetone on gastrointestinal secretion in rats. , 1982, European journal of pharmacology.

[26]  H. Fujisaki,et al.  Antiulcer effect of geranylgeranylacetone, a new acyclic polyisoprenoid on experimentally induced gastric and duodenal ulcers in rats. , 1981, Arzneimittel-Forschung.